A somatostatin analog in the octreotide/lanreotide family, studied for variceal bleeding.
Also known as: Sanvar · RC-160 · somatostatin analog
Part of the Foundational & therapeutic peptides cluster
Overview
Vapreotide is a synthetic cyclic octapeptide analog of somatostatin that activates somatostatin receptors. It has been studied and used in some countries for esophageal variceal bleeding related to cirrhosis, though regulatory status varies by market. This page is educational and is not medical advice.
Source & context
Biological / chemical source: Synthetic cyclic octapeptide analog of somatostatin
Primary research or clinical context: Somatostatin analog studied and used in some countries for esophageal variceal bleeding; regulatory status varies by market
Somatostatin analog family
Native somatostatin has a very short half-life. Cyclic analogs such as octreotide, lanreotide, and vapreotide were engineered for greater stability and receptor selectivity, expanding the somatostatin pathway into practical therapeutics.
Studied applications
Because somatostatin agonists reduce splanchnic blood flow and inhibit several gut hormones, vapreotide has been examined in gastrointestinal bleeding and other secretory conditions. Availability and approval differ across countries.
FAQ about Vapreotide
What is Vapreotide?+
Vapreotide is a synthetic cyclic octapeptide analog of somatostatin that activates somatostatin receptors. It has been studied and used in some countries for esophageal variceal bleeding related to cirrhosis, though regulatory status varies by market. This page is educational and is not medical advice.
Is Vapreotide an approved medicine?+
Vapreotide is discussed here as a research / educational topic. Somatostatin analog studied and used in some countries for esophageal variceal bleeding; regulatory status varies by market. This is not medical advice.
What is the typical length of Vapreotide?+
Vapreotide is commonly described as approximately 8 amino acids (Somatostatin analog (cyclic octapeptide)).